Sanofi Names EVP of Strategy and Business Development

From DCAT Value Chain Insights (VCI)

By People On The Move posted 02-10-2016 07:09


Sanofi has appointed Muzammil Mansuri as a new member of the Executive Committee, effective February 22, 2016. Mr. Mansuri joins Sanofi from Gilead Sciences and will take the position of Executive Vice President, Strategy & Business Development. He will be responsible for all Group strategic planning, business development, strategic intelligence, alliance management and the Sanofi Genzyme Bio Ventures fund.

A dual citizen of the US and United Kingdom, Mr. Mansuri has more than 35 years of experience beginning in 1981 with Shell Research Limited, where he began as a research scientist. After Shell, he spent several years with Bristol-Myers Company in various R&D roles with increasing responsibility. From 2007 to 2010, Mr. Mansuri was Chairman and CEO at CGI Pharmaceuticals. Mr. Mansuri's most recently was Senior Vice President, Research & Development Strategy and Corporate Development at Gilead Sciences.

Source: Sanofi


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription